Stanford medicine releases its research on Apple Heart watches
Category: #health  By Pankaj Singh  Date: 2019-11-15
  • share
  • Twitter
  • Facebook
  • LinkedIn

Stanford medicine releases its research on Apple Heart watches
  • The study comprised enrollment of over 400,000 people, making it one of the biggest research efforts.
     
  • It also saw approximately 2,000 of people receiving notification of irregular pulse.

California-based Stanford Medicine recently came out with its long-awaited results from the Apple Heart Study, which represents one of the biggest research effort that depends on consumer application to get a good understanding about human health.

Reportedly, the study focused on how Apple Watch could act as a viable alternative to detect atrial fibrillation, a disorder that is often linked with a growing risk of stroke. Moreover, it comprised of more than 400,000 participants over eight months who owned an Apple Watch.

Apparently, Apple had sponsored the study and thereby owns the data which is still kept at Stanford. Moreover, the study’s methods and protocol were cleared in advance by the central institutional review board to safeguard the patient’s privacy.

Reliable reports claim that Atrial fibrillation commonly affects roughly 6 million citizens in the United States, with a majority of unaware of them having it. The disease could potentially be detected by employing algorithms and sensors. This has further made it a major target for makers of wearable devices.

Notably, Apple has integrated an electrocardiogram sensor in its Apple Watch Series 5 and Series 4 gadgets. These sensors allow the gadget to observe the rhythm of the heart and delivers health information quickly to its users.

Speaking on the move, Jeff Wessler, Cardiologist and Founder of the Heartbeat cardiology clinics, said that it is hard to identify atrial fibrillation in healthy people that are commonly in their mid-30s. Wessler has already begun to implement the patient’s data based on their Apple Watches and claims that diagnosis based on these devices will become a common trend in the future.

Source Credit: https://www.cnbc.com/2019/11/13/apple-releases-heart-study-results.html



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

GE Healthcare Life Sciences & ASLS unite to advance 3D biofabrication
GE Healthcare Life Sciences & ASLS unite to advance 3D biofabrication
By Pankaj Singh

 

  • The alliance is aimed at personalizing regenerative tissue manufacturing processes
  • Vascularized printed cells are set to pave the way for more complex biolog...

Hummingbird Bio secures $19M to expand antibody therapeutics portfolio
Hummingbird Bio secures $19M to expand antibody therapeutics portfolio
By Pankaj Singh

Hummingbird Bioscience, an advanced biotherapeutics company, recently announced it has raised USD 19 million in a Series B funding round. Apparently, the financing round was co-led by GNTech Venture Capital and Mirae A...

Acadia announces positive results of Phase 3 trial to treat psychosis
Acadia announces positive results of Phase 3 trial to treat psychosis
By Pankaj Singh

Acadia Pharmaceuticals, a renowned US-based biopharmaceutical company dedicated to the development of treatments for central nervous system disorders, reportedly announced positive outcomes from its Phase 3 HARMONY stu...